GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

GoodRx Holdings, Inc.NASDAQ: GDRX

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q1 FY2026 gross profit of $152.06M fell 19.8% year over year, behind the -8.9% change in trailing-twelve-month gross profit. Sequentially, it fell 14.2% from the prior quarter. Over 3 fiscal years it compounded at +1.8% a year.

Context

  • Gross profit amounted to 92.8% of revenue in FY2025, down 1.1 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -19.8% toward the trailing-twelve-month pace of -8.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$152.06M-14.2% QoQ
Last fiscal yearDec 2025
$739.26M-0.7% YoY
LTMMar 2026
$681.98M-8.9% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.8%——
1 year-0.7%——
3-year CAGR+1.8%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
739.26M USD
Year-over-year change
-0.7%
4-year CAGR
+1.4%

Gross Profit vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's LTM Mar 2026 gross profit of $681.98M is the 2nd highest of the 4 companies compared; the peer median is $188.46M.
  • Its year-over-year change of -8.9% is the lowest of 4, against a peer median of -8.3%.
  • Gross profit amounts to 86.6% of revenue for GDRX, versus a peer median of 65.6%.
GDRX Competitors Peer median
Gross Profit for GDRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TDOCTeladoc Health, Inc.LTM Mar 2026$1.65B -8.3%+1.9%65.6%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$681.98M -8.9%+1.8%86.6%
LFMDLifeMD, Inc.LTM Mar 2026$188.46M -8.4%+15.5%85.9%
AMWLAmerican Well CorporationLTM Mar 2026$118M +1.9%+4.4%49.7%
Peer median (excluding GDRX) $188.46M-8.3%+4.4%65.6%

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue745.42M766.55M750.27M792.32M796.85M
Cost of Revenue46.72M65.08M66.93M48.22M57.6M
Gross Profit698.71M701.48M683.34M744.11M739.26M
Gross Margin93.7%91.5%91.1%93.9%92.8%
Research & Development125.86M143.14M135.84M123.75M121.03M
Selling, General & Admin524.9M502.42M466.84M484.98M445.52M
Operating Expenses685.3M699.74M710.35M678.26M651.76M
Depreciation & Amortization34.54M54.18M107.67M69.54M85.22M
EBITDA48M65.19M108.82M153.92M184.36M
EBITDA Margin6.4%8.5%14.5%19.4%23.1%
Operating Income13.41M1.74M(27.01M)65.85M87.49M
Operating Margin1.8%0.2%-3.6%8.3%11.0%
Interest Income59K9.27M32.17M23.27M10.93M
Interest Expense23.64M34.24M56.73M52.92M42.61M
Other Income / Expenses(23.58M)(24.97M)(28.57M)(34.39M)(30.95M)
Income Before Tax(10.18M)(23.23M)(55.57M)31.46M56.54M
Pre-Tax Margin-1.4%-3.0%-7.4%4.0%7.1%
Income Tax Expense15.08M9.6M(46.7M)15.07M26.1M
Net Income(25.25M)(32.83M)(8.87M)16.39M30.44M
Net Margin-3.4%-4.3%-1.2%2.1%3.8%
EPS (Basic)(0.06)(0.08)(0.02)0.040.09
EPS (Diluted)(0.06)(0.08)(0.02)0.040.09
Weighted Avg Shares409.98M412.86M410.32M385.74M356.33M
Weighted Avg Shares (Diluted)409.98M412.86M410.32M392.17M356.97M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.